Hanshen Yang

492 total citations
16 papers, 244 citations indexed

About

Hanshen Yang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Hanshen Yang has authored 16 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Hanshen Yang's work include Pancreatic and Hepatic Oncology Research (5 papers), Immune cells in cancer (5 papers) and Autophagy in Disease and Therapy (3 papers). Hanshen Yang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Immune cells in cancer (5 papers) and Autophagy in Disease and Therapy (3 papers). Hanshen Yang collaborates with scholars based in China, United States and Saudi Arabia. Hanshen Yang's co-authors include Xiaozhen Zhang, Tingbo Liang, Mengyi Lao, Xueli Bai, Honggang Ying, Jian Xu, Yi Duan, Lihong He, Kang Sun and Muchun Li and has published in prestigious journals such as Nature Nanotechnology, Oncogene and Science Advances.

In The Last Decade

Hanshen Yang

15 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanshen Yang China 9 130 111 91 37 30 16 244
Robert J. Van Gulick United States 9 122 0.9× 129 1.2× 68 0.7× 29 0.8× 24 0.8× 14 242
Angelica Pace Italy 8 77 0.6× 114 1.0× 90 1.0× 69 1.9× 30 1.0× 10 252
Ryan C. Augustin United States 6 153 1.2× 125 1.1× 114 1.3× 52 1.4× 28 0.9× 15 300
Victoria Kim United States 4 205 1.6× 85 0.8× 143 1.6× 34 0.9× 20 0.7× 6 301
S Buchholz Germany 5 204 1.6× 138 1.2× 88 1.0× 89 2.4× 36 1.2× 11 333
Ellen Scott United States 5 183 1.4× 94 0.8× 170 1.9× 47 1.3× 38 1.3× 6 299
Maximilian M. L. Knott Germany 7 133 1.0× 104 0.9× 138 1.5× 35 0.9× 49 1.6× 11 276
Rachel A. Woolaver United States 9 158 1.2× 144 1.3× 132 1.5× 53 1.4× 40 1.3× 12 317
Zhitong Niu China 5 138 1.1× 191 1.7× 98 1.1× 93 2.5× 32 1.1× 6 331
Madison Canning United States 3 198 1.5× 142 1.3× 129 1.4× 89 2.4× 63 2.1× 5 372

Countries citing papers authored by Hanshen Yang

Since Specialization
Citations

This map shows the geographic impact of Hanshen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanshen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanshen Yang more than expected).

Fields of papers citing papers by Hanshen Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanshen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanshen Yang. The network helps show where Hanshen Yang may publish in the future.

Co-authorship network of co-authors of Hanshen Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Hanshen Yang. A scholar is included among the top collaborators of Hanshen Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanshen Yang. Hanshen Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lao, Mengyi, Xiaozhen Zhang, Zejun Li, et al.. (2025). Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy. Cancer Communications. 45(8). 1010–1037. 1 indexed citations
2.
Liang, Kaiyu, Shuheng Zhang, Lin Zheng, et al.. (2025). Spatiotemporal-adaptive nanotherapeutics promote post-injury regeneration in ageing through metabolic modulation. Nature Nanotechnology. 20(11). 1700–1712. 1 indexed citations
3.
Zhang, Xiaozhen, Mengyi Lao, Kang Sun, et al.. (2025). Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma. Science Advances. 11(21). eadv0558–eadv0558. 4 indexed citations
4.
He, Lihong, Yan Chen, Kang Sun, et al.. (2024). Reprograming immunosuppressive microenvironment by eIF4G1 targeting to eradicate pancreatic ductal adenocarcinoma. Cell Reports Medicine. 5(10). 101731–101731. 4 indexed citations
5.
Zhang, Xiaozhen, Mengyi Lao, Hanshen Yang, et al.. (2024). Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy. 20(6). 1314–1334. 39 indexed citations
6.
Duan, Yi, Xiaozhen Zhang, Honggang Ying, et al.. (2023). Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix. Oncogene. 42(25). 2061–2073. 21 indexed citations
7.
Chen, Yan, et al.. (2023). The “Self-eating” of cancer-associated fibroblast: A potential target for cancer. Biomedicine & Pharmacotherapy. 163. 114762–114762. 11 indexed citations
8.
He, Lihong, et al.. (2023). Immune Checkpoint Neuropilins as Novel Biomarkers and Therapeutic Targets for Pancreatic Cancer. Cancers. 15(8). 2225–2225. 3 indexed citations
9.
Lou, Yu, Xiaozhen Zhang, Hanshen Yang, et al.. (2023). Integrative analysis identified two subtypes and a taurine-related signature to predict the prognosis and efficacy of immunotherapy in hepatocellular carcinoma. Computational and Structural Biotechnology Journal. 21. 5561–5582. 2 indexed citations
10.
Zhang, Sirui, Xiaozhen Zhang, Hanshen Yang, Tingbo Liang, & Xueli Bai. (2023). Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(1). 189022–189022. 10 indexed citations
11.
Zhang, Xiaozhen, Mengyi Lao, Jian Xu, et al.. (2022). Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors. Journal for ImmunoTherapy of Cancer. 10(3). e003982–e003982. 46 indexed citations
12.
Lao, Mengyi, Xiaozhen Zhang, Hanshen Yang, Xueli Bai, & Tingbo Liang. (2022). RCAN1-mediated calcineurin inhibition as a target for cancer therapy. Molecular Medicine. 28(1). 69–69. 10 indexed citations
13.
Yang, Hanshen, Xiaozhen Zhang, Mengyi Lao, et al.. (2022). Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer. Cell Death and Differentiation. 30(2). 560–575. 44 indexed citations
14.
Lao, Mengyi, Xiaozhen Zhang, Tao Ma, et al.. (2021). Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells. Oncogene. 40(17). 3136–3151. 14 indexed citations
15.
Ying, Honggang, Xiaozhen Zhang, Yi Duan, et al.. (2021). Non-cytomembrane PD-L1: An atypical target for cancer. Pharmacological Research. 170. 105741–105741. 34 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert J. Van Gulick Breakdown of academic impact, for papers by Angelica Pace Breakdown of academic impact, for papers by Ryan C. Augustin Breakdown of academic impact, for papers by Victoria Kim Breakdown of academic impact, for papers by S Buchholz Breakdown of academic impact, for papers by Ellen Scott Breakdown of academic impact, for papers by Maximilian M. L. Knott Breakdown of academic impact, for papers by Rachel A. Woolaver Breakdown of academic impact, for papers by Zhitong Niu Breakdown of academic impact, for papers by Madison Canning
Rankless by CCL
2026